Snehit Prabhu

13PUBLICATIONS
57CO-AUTHORS
Haematological tumoursHaematologyCancer therapy (excl. chemotherapy and radiation therapy)Infant and child healthAdolescent health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Sep 11, 2026
Peripheral Blasts at Apheresis as a Risk Factor for Survival following Tisagenlecleucel in Children and Young Adults.

|Jul 17, 2026
HLH-like syndromes associate with increased risk of death and CD19- relapse after CAR T in pediatric B-ALL.

|Jul 21, 2025
Characterization and prediction of prolonged severe neutropenia in pediatric patients receiving tisagenlecleucel.

Swati Naik, Subodh Selukar, Aimee C Talleur

|Mar 01, 2023
HLH-like toxicities predict poor survival after the use of tisagenlecleucel in children and young adults with B-ALL.

Kevin O McNerney, Stephanie J Si Lim, Kyle Ishikawa

|Sep 15, 2022
Outcomes After Nonresponse and Relapse Post-Tisagenlecleucel in Children, Adolescents, and Young Adults With B-Cell Acute Lymphoblastic Leukemia.

Liora M Schultz, Anne Eaton, Christina Baggott

|Aug 08, 2022
Higher doses of tisagenlecleucel are associated with improved outcomes: a report from the pediatric real-world CAR consortium.

Heather E Stefanski, Anne Eaton, Christina Baggott

Pageof 3

Frequent Collaborators

13 joint publications

Crystal L Mackall

12 joint publications

Jenna Rossoff

8 joint publications

Muna Qayed

7 joint publications

Patrick Brown